Screener
UroGen Pharma URGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.79B.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's market capitalization?
- UroGen Pharma (URGN) reported market capitalization of $1.79B in Q2 2026.
- How has UroGen Pharma's market capitalization changed year-over-year?
- UroGen Pharma's market capitalization increased by 182.0% year-over-year, from $635.82M to $1.79B.
- What is the long-term trend for UroGen Pharma's market capitalization?
- Over 5 years (2020 to 2025), UroGen Pharma's market capitalization has grown at a 22.1% compound annual growth rate (CAGR), from $404.01M to $1.1B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about UroGen Pharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude